Premium
Is the S.M.A.R.T ® stent the smart option to treat femoropopliteal disease?
Author(s) -
Patel Nachiket J.,
Heuser Richard R.
Publication year - 2018
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.27696
Subject(s) - medicine , stent , randomized controlled trial , radiology , femoral artery , popliteal artery , superficial femoral artery , arterial disease , endovascular treatment , surgery , vascular disease , aneurysm
KEY POINTS The femoropopliteal (FP) artery is a common site for endovascular interventions. S.M.A.R.T.® stent is effective in treating FP lesions with results comparable to other treatment options. Without head‐to‐head randomized controlled trials, the ideal treatment strategy for FP lesions remains unknown.